Articles on "Personalized Medicine"

Obstructive sleep apnea (OSA) is a sleep disorder that impacts millions globally. In the United States alone, it is estimated that approximately 39 million adult Americans suffer from sleep apnea, with many cases undiagnosed.

In recent years, Semaglutide has emerged as a noteworthy ingredient in medications that address metabolic health and weight loss. Many of these medications, including Ozempic®, were originally developed to manage blood sugar levels in patients with Type 2 Diabetes, but were later found to have a big role in supporting weight management.

At HDRx, we are committed to providing high-quality, customized medication solutions like compounded Semaglutide, for those affected by the Ozempic/Wegovy shortage.

Many patients suffer from difficult-to-address gastrointestinal (GI) and rectal health conditions like hemorrhoids and anal fissures.